| [1] |
LI Yumeng, DU Xiaoyu, QIU bo, WU Huizhen.
Pharmacological effects and clinical evaluation of toludesvenlafaxine in the treatment of depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(3): 419-426.
|
| [2] |
HE Hui, GUO Mingliang, RAN Licheng, WANG Yajun.
Research progress on the effect of hippocampal FXR regulation of CREB-BDNF signaling pathway on depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 265-271.
|
| [3] |
A Nan, XIAO Fan, SONG Yaheng, YU Hong.
The in vivo material basis responsible for the antidepressant activity of saffron glycoside-I
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(12): 1409-1418.
|
| [4] |
ZHANG Taotao, SU Wenxiu, TIAN Limin.
Research progress on the relationship between subclinical hypothyroidism and depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 954-960.
|
| [5] |
HE Teng, XU Xiangyang, XU Xiangqing, LIU Cunming, YANG Chun.
Ketamine for depression treatment: past, present, and future
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1125-1132.
|
| [6] |
WANG Yeqing, WANG Yuhong, LIU Jian, ZHAO Hongqing, ZOU Manshu.
Research progress of relevance between cholecystokinin and depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 672-679.
|
| [7] |
CHEN Ying, YUAN Yonggui.
Research progress in the treatment of depression with monome of Chinese herb, drug pairs, compound prescriptions and Chinese patent drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 586-593.
|
| [8] |
YANG Shitao, ZHU Yihong, TANG Wenxin.
Effects of aripiprazole combined with duloxetine on the treatment effect and VEGF level in patients with refractory depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 937-942.
|
| [9] |
GE Wei, SHENG Wenyan, XU Qibing, LI Qiushi, SU Lingya, WU Shuangqing.
Effects of SSRI antidepressant sertraline on ocular surface function in patients with postpartum depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 440-446.
|
| [10] |
FENG Rui, ZHANG Jiali, HE Mingchao, LI Yue, ZHANG Yan.
Pharmacological targets and clinical application of traditional Chinese medicine and active components in the prevention and treatment for depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 467-474.
|
| [11] |
WANG Sijie,ZHANG Jun,LI Qian,HUANG Hua,WANG Jingjing,ZHOU Qiong,YAO Qin.
Research progress on the safety and effectiveness of escitalopram in the treatment of pregnant women with depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1070-1074.
|
| [12] |
ZHOU Yancan.
Effects of agomelatine on depressive disorder and brain-derived neurotrophic factor ZHOU Yancan
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 699-703.
|
| [13] |
CHEN Lianzhou, LI Songhua, PU Ben.
Effects of aripiprazole combined with escitalopram oxalate on DA, 5-HT and cortisol in patients with severe depression
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 446-450.
|
| [14] |
SHEN Lei, WANG Keke, YANG Jingke, ZHAO Juntao, MENG Xiangguang, YUAN Yiqiang.
Advances in drugs and genetic pharmacology for heart failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(3): 343-349.
|
| [15] |
WU Juan, WU Yongjun, LI Zhi, ZENG Chang, LI Zhenfeng, TANG Yi, LU Miao, ZHANG Xuechun, ZHANG Wanyong, WANG Danhui, LIU Chenrui.
Epigenetic regulation of Dapper family proteins in cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1434-1440.
|